IRIDEX Corporation (IRIX) vs VistaGen Therapeutics, Inc. (VTGN)

A side-by-side comparison of IRIDEX Corporation and VistaGen Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IRIX vs VTGN

growth of $100 · dividends reinvested · last 10y
IRIX -95.2% (-26.2%/yr)VTGN -99.8% (-46.3%/yr)IRIX compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020182020202220242026$5$0
IRIX VTGN

IRIX vs VTGN: by the numbers

  • •IRIX is the larger company ($12M vs $11M market cap).
  • •Both run net losses; IRIX's is the smaller (-6.88% vs -2702.64% net margin).
  • •VTGN grew revenue faster over the past five years (11.63% vs -0.57% CAGR).

Metrics side by side

Valuation

MetricIRIXVTGN
P/S ratio0.244.54
P/B ratioN/A0.46

Profitability

MetricIRIXVTGN
Gross margin36.23%100.00%
Operating margin-5.39%-5683.69%
Net margin-6.88%-2702.64%
ROE-97.47%-276.21%
ROIC-19.53%-275.74%

Growth (annualized)

MetricIRIXVTGN
Revenue CAGR (5Y)-0.57%11.63%
Total return CAGR (5Y)-38.13%-68.35%

Frequently asked

Which has grown faster, IRIX or VTGN?
Over the past five years, VTGN grew revenue faster — IRIX at a -0.57% CAGR versus VTGN at 11.63%.
How have IRIX and VTGN total returns compared?
Over the past 10 years, IRIX delivered -26.14% and VTGN delivered -46.28% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.